Fortress Biotech Inc
(FRA:CNB1)
€
4.131
0 (0%)
Market Cap: 32.09 Mil
Enterprise Value: 30.08 Mil
PE Ratio: 0
PB Ratio: 2.19
GF Score: 62/100 Fortress Biotech Inc Corporate Update Presentation at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 30, 2021 / 03:30PM GMT
Release Date Price:
€45
(-5.06%)
Brent Slava
Benzinga - Moderator
Presentation at Benzinga Healthcare Small Cap Conference (Virtual)
Sep 30, 2021 / 03:30PM GMT
=====================
Corporate Participants
=====================
* Lindsay Rosenwald
Fortress Biotech, Inc. - President, Chairman, CEO
=====================
Conference Call Participants
=====================
* Brent Slava
Benzinga - Moderator
=====================
-
Lindsay Rosenwald
Fortress Biotech, Inc. - President, Chairman, CEO
The show will continue, here we go. We're jumping right into it. Next presenter is from a company called Fortress Bio. It's ticker FBIO, and I'm going to be welcoming on here, the Chairman, Lindsay Rosenwald. Lindsay, how are you?
-
Brent Slava
Benzinga - Moderator
Hey, Brent. I'm good, how are you?
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot